Tarsus Pharmaceuticals, Inc. Quarterly Operating Margin in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Tarsus Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q1 2021 to Q3 2024.
  • Tarsus Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2024 was -108 %, a 86.3% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. annual Operating Margin for 2023 was -821 %, a 238% decline from 2022.
  • Tarsus Pharmaceuticals, Inc. annual Operating Margin for 2022 was -243 %, a 1039% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -108 +683 +86.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -188 +578 +75.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -366 -121 -49.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -821 -578 -238% Oct 1, 2023 Dec 31, 2023
Q3 2023 -792 -407 -106% Jul 1, 2023 Sep 30, 2023
Q2 2023 -766 -450 -143% Apr 1, 2023 Jun 30, 2023
Q1 2023 -245 -69.7 -39.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -243 -222 -1039% Oct 1, 2022 Dec 31, 2022
Q3 2022 -384 -368 -2273% Jul 1, 2022 Sep 30, 2022
Q2 2022 -316 -309 -4733% Apr 1, 2022 Jun 30, 2022
Q1 2022 -176 -133 -315% Jan 1, 2022 Mar 31, 2022
Q4 2021 -21.3 Oct 1, 2021 Dec 31, 2021
Q3 2021 -16.2 Jul 1, 2021 Sep 30, 2021
Q2 2021 -6.53 Apr 1, 2021 Jun 30, 2021
Q1 2021 -42.4 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.